Ontrak (OTRK) 10-Q 14 Nov 17 2017 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2017	Nov. 13, 2017
Document Information [Line Items]
Entity Registrant Name	CATASYS, INC.
Entity Central Index Key	1,136,174
Trading Symbol	cats
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		15,889,171
Document Type	10-Q
Document Period End Date	Sep. 30, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q3
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands		Sep. 30, 2017	Dec. 31, 2016
Current assets
Cash and cash equivalents		$ 6,926	$ 851
Receivables, net of allowance for doubtful accounts of $277 and $0, respectively		709	1,052
Prepaids and other current assets		307	420
Total current assets		7,942	2,323
Long-term assets
Property and equipment, net of accumulated depreciation of $1,751 and $1,620, respectively		553	410
Deposits and other assets		371	371
Total Assets		8,866	3,104
Current liabilities
Accounts payable		806	870
Accrued compensation and benefits		901	2,089
Deferred revenue		3,180	1,525
Other accrued liabilities		579	575
Short term debt, related party, net of discount $0 and $216, respectively			9,796
Derivative liability			8,122
Total current liabilities		5,466	22,977
Long-term liabilities
Deferred rent and other long-term liabilities		49	117
Capital leases		6	31
Warrant liabilities		41	5,307
Total Liabilities		5,562	28,432
Stockholders' equity/(deficit)
Preferred stock, $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding		0	0
Common stock, $0.0001 par value; 500,000,000 shares authorized; 15,889,171 and 9,214,743 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively	[1]	2	1
Additional paid-in-capital		293,945	254,390
Accumulated deficit		(290,643)	(279,719)
Total Stockholders' Equity/(Deficit)		3,304	(25,328)
Total Liabilities and Stockholders' Equity/(Deficit)		$ 8,866	$ 3,104
[1]	The financial statements have been retroactively restated to reflect the 1-for-6 reverse-stock split that occurred on April 25, 2017.

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2017USD ($)$ / sharesshares	Sep. 30, 2017USD ($)$ / sharesshares	Dec. 31, 2016USD ($)$ / sharesshares
Receivables, allowance for doubtful accounts | $	$ 277	$ 277	$ 0
Property and equipment, accumulated dereciation | $	1,751	1,751	1,620
Short term debt, related party, discount | $	$ 0	$ 0	$ 216
Preferred stock, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000	50,000,000
Preferred stock, shares issued (in shares)	0	0	0
Preferred stock, shares outstanding (in shares)	0	0	0
Common stock, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	500,000,000	500,000,000	500,000,000
Common stock, shares issued (in shares)	15,889,171	15,889,171	9,214,743
Common stock, shares outstanding (in shares)	15,889,171	15,889,171	9,214,743
Reverse Stock Split [Member]
Reverse stock split	6	6

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Revenues:
Healthcare services revenues		$ 1,195,000	$ 1,336,000	$ 4,682,000	$ 3,287,000
Operating expenses
Cost of healthcare services		1,664,000	1,253,000	4,361,000	3,381,000
General and administrative		2,575,000	2,195,000	8,144,000	6,518,000
Depreciation and amortization		47,000	38,000	131,000	102,000
Total operating expenses		4,286,000	3,486,000	12,636,000	10,001,000
Loss from operations		(3,091,000)	(2,150,000)	(7,954,000)	(6,714,000)
Other income		16,000	15,000	44,000	90,000
Interest expense		(1,000)	(3,215,000)	(3,408,000)	(4,139,000)
Loss on conversion of note				(1,356,000)
Loss on issuance of common stock				(145,000)
Change in fair value of derivative liability			(3,484,000)	132,000	(6,328,000)
Change in fair value of warrant liability		(2,000)	1,423,000	1,767,000	673,000
Loss from operations before provision for income taxes		(3,078,000)	(7,411,000)	(10,920,000)	(16,418,000)
Provision for income taxes		2,000	2,000	4,000	7,000
Net Loss		$ (3,080,000)	$ (7,413,000)	$ (10,924,000)	$ (16,425,000)
Basic and diluted net loss from operations per share: (in dollars per share)		$ (0.19)	$ (0.81)	$ (0.84)	$ (1.79)
Basic weighted number of shares outstanding (in shares)	[1]	15,889	9,174	13,031	9,170
[1]	The financial statements have been retroactively restated to reflect the 1-for-6 reverse-stock split that occurred on April 25, 2017.

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals)	Apr. 25, 2017	Sep. 30, 2017	Sep. 30, 2017
Reverse Stock Split [Member]
Reverse stock split	6	6	6

Condensed Consolidated Stateme6

Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Operating activities:
Net loss	$ (10,924,000)	$ (16,425,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	131,000	102,000
Amortization of debt discount and issuance costs included in interest expense	3,335,000	3,673,000
Provision for doubtful accounts	307,000	46,000
Deferred rent	(60,000)	(52,000)
Share-based compensation expense	191,000	523,000
Common stock issued for services	181,000
Loss on conversion of convertible debenture	1,356,000
Loss on issuance of common stock	145,000
Fair value adjustment on warrant liability	(1,767,000)	(673,000)
Fair value adjustment on derivative liability	(132,000)	6,328,000
Changes in current assets and liabilities:
Receivables	36,000	(345,000)
Prepaids and other current assets	113,000	270,000
Deferred revenue	1,655,000	1,548,000
Accounts payable and other accrued liabilities	85,000	554,000
Net cash used by operating activities	(5,348,000)	(4,451,000)
Investing activities:
Purchases of property and equipment	(274,000)	(102,000)
Deposits and other assets		16,000
Net cash used by investing activities	(274,000)	(86,000)
Financing activities:
Proceeds from the issuance of common stock and warrants	16,458,000
Proceeds from issuance of bridge loan	1,300,000
Payments on convertible debenture	(4,363,000)
Proceeds from issuance of senior promissory note, related party		5,505,000
Proceeds from advance from related party		225,000
Payment on advance from related party		(225,000)
Transactions costs	(1,667,000)
Capital lease obligations	(31,000)	(41,000)
Net cash provided by financing activities	11,697,000	5,464,000
Net increase in cash and cash equivalents	6,075,000	927,000
Cash and cash equivalents at beginning of period	851,000	916,000
Cash and cash equivalents at end of period	6,926,000	1,843,000
Supplemental disclosure of cash paid
Interest
Income taxes	40,000	46,000
Supplemental disclosure of non-cash activity
Common stock issued for exercise of warrants		45,000
Property and equipment acquired through capital leases and other financing		34,000
Common Stock Issued Upon Settlement of Deferred Compensation to Officer [Member]
Supplemental disclosure of non-cash activity
Common stock issued upon settlement of deferred compensation to officer	1,122,000
Common Stock Issued for Conversion of Debt and Accrued Interest [Member]
Supplemental disclosure of non-cash activity
Common stock issued for conversion of debt and accrued interest	$ 7,163,000

Note 1 - Basis of Consolidation

Note 1 - Basis of Consolidation and Presentation	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	Note 1. Basis of Consolidation and Presentation The accompanying unaudited condensed consolidated financial statements for Catasys, Inc. and its subsidiaries have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and instructions to Form 10 not Interim results are not may 10 December 31, 2016, December 31, 2016,

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Significant Accounting Policies [Text Block]	Note 2. Revenue Recognition Our Catasys contracts are generally designed to provide cash fees to us on a monthly basis or an upfront case rate based on enrolled members. To the extent our contracts may may not twelve Cost of Services Cost of healthcare services consists primarily of salaries related to our care coaches, outreach specialists and other staff directly involved in member care, healthcare provider claims payments, and fees charged by our third third Trak TM Cash Equivalents and Concentration of Credit Risk We consider all highly liquid investments with an original maturity of three . The deposited cash may September 30, 2017, $6.8 For the nine September 30, 2017, three 90% five 96% Basic and Diluted Income ( Loss ) per Share Basic income (loss) per share is computed by dividing the net income (loss) to common stockholders for the period by the weighted average number of shares of common stock outstanding during the period. Diluted income (loss) per share is computed by dividing the net income (loss) for the period by the weighted average number of shares of common stock and dilutive common equivalent shares outstanding during the period. Common equivalent shares, consisting of 2,255,381 1,178,821 nine September 30, 2017 2016, stock options and warrants have been excluded from the diluted earnings per share calculation as their effect is anti-dilutive. Share-Based Compensation Our 2017 “2017 2,333,334 and an additional 243,853 2010 “2010 422A no ten three five September 30, 2017, 243,853 2,333,334 2017 S hare-based compensation expense attributable to continuing operations were $32,000 $191,000 three nine September 30, 2017, $174,000 $523,000 2016, Stock Options – Employees and Directors We measure and recognize compensation expense for all share-based payment awards made to employees and directors based on estimated fair values on the date of grant. We estimate the fair value of share-based payment awards using the Black-Scholes option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the consolidated statements of operations. Share-based compensation expense recognized for employees and directors for the three nine September 30, 2017 $32,000 $191,000, $174,000 $523,000, 2016, For share-based awards issued to employees and directors, share-based compensation is attributed to expense using the straight-line single option method. Share-based compensation expense recognized in our consolidated statements of operations for the three nine September 30, 2017 2016 There were no three nine September 30, 2017 2016, 2017 three nine September 30, 2017 Weighted Avg. Shares Exercise Price Balance December 31, 2016 244,046 $ 39.06 Granted - $ - Cancelled (193 ) $ (245.47 ) Balance March 31, 2017 243,853 $ 38.90 Granted - $ - Cancelled - $ - Balance June 30, 2017 243,853 $ 38.90 Granted - $ - Cancelled - $ - Balance September 30, 2017 243,853 $ 38.90 The expected volatility assumptions have been based on the historical and expected volatility of our stock, measured over a period generally commensurate with the expected term. The weighted average expected option term for the three and nine September 30, 2017 2016, No. 107 110 As of September 30, 2017, $127,500 2017 1.02 Stock Options and Warrants – Non-employees We account for the issuance of options and warrants for services from non-employees by estimating the fair value of warrants issued using the Black-Scholes pricing model. This model’s calculations include the option or warrant exercise price, the market price of shares on grant date, the weighted average risk-free interest rate, the expected life of the option or warrant, and the expected volatility of our stock and the expected dividends. For options and warrants issued as compensation to non-employees for services that are fully vested and non-forfeitable at the time of issuance, the estimated value is recorded in equity and expensed when the services are performed and benefit is received . For unvested shares, the change in fair value during the period is recognized in expense using the graded vesting method. There were no three nine September 30, 2017 2016. There was no three nine September 30, 2017 2016. Common Stock In April 2017, we entered into an underwriting agreement with Joseph Gunnar & Co., LLC (“Joseph Gunnar”), as underwriter in connection with a public offering of the Company’s securities. Pursuant to the underwriting agreement, we agreed to issue and sell an aggregate 3,125,000 $4.80 $4.464 April 28, 2017. $15.0 Pursuant to the underwriting agreement with Joseph Gunnar, we granted the underwriters a 45 468,750 May, 303,750 $1.5 In connection with the public offering, our common stock began trading on the NASDAQ Capital Market (“NASDAQ”) under the symbol “CATS” beginning on April 26, 2017. In April 2017, one hundred 100% convertible debentures and received 2,982,994 $1.4 nine September 30, 2017. In April 2017, $1.1 233,734 As a result, we recognized a loss on settlement of liability totaling $83,807 In April 2017, 1 6 of our common stock, pursuant to which each six one not No All stock options and warrants to purchase common stock outstanding and our common stock reserved for issuance under our equity incentive plans immediately prior to the reverse stock split were appropriately adjusted by dividing the number of affected shares of common stock by six six There were 0 28,985 three nine September 30, 2017 no 2016. Income Taxes We have recorded a full valuation allowance against our otherwise recognizable deferred tax assets as of September 30, 2017. not September 30, 2017. 740, not not We assess our income tax positions and record tax benefits for all years subject to examination based upon our evaluation of the facts, circumstances and information available at the reporting date. For those tax positions where there is greater than 50% may 50% no September 30, 2017 Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities recorded at fair value in the consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure fair value. The fair value hierarchy distinguishes between ( 1 2 ’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three three Level Input: Input Definition: Level I Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date. Level II Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date. Level III Unobservable inputs that reflect management ’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The following table summarizes fair value measurements by level at September 30, 2017 Balance at September 30, 2017 (Amounts in thousands) Level I Level II Level III Total Certificates of deposit 106 - - 106 Total assets 106 - - 106 Warrant liabilities - - 41 41 Total liabilities - - 41 41 Financial instruments classified as Level III in the fair value hierarchy as of September 30, 2017, Warrant Liabilities The following table summarizes our fair value measurements using significant Level III inputs, and changes therein, for the three nine September 30, 2017: Level III Level III Warrant Derivative (Dollars in thousands) Liabilities (Dollars in thousands) Liabilities Balance as of December 31, 2016 $ 5,307 Balance as of December 31, 2016 $ 8,122 Issuance of warrants 2,405 Issuance of convertible debentures - Change in fair value 5,181 Change in fair value 10,596 Balance as of March 31, 2017 $ 12,893 Balance as of March 31, 2017 $ 18,718 Issuance (exercise) of warrants, net 269 Issuance of convertible debentures - Change in fair value (6,950 ) Change in fair value (10,728 ) Write off of warrants (6,174 ) Write off of derivative liability (7,990 ) Balance as of June 30, 2017 $ 38 Balance as of June 30, 2017 $ - Issuance (exercise) of warrants, net - Issuance of convertible debentures - Expiration of warrants - Expiration of warrants - Change in fair value 2 Change in fair value - Balance as of September 30, 2017 $ 40 Balance as of September 30, 2017 $ - Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Additions and improvements to property and equipment are capitalized at cost. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, which range from two seven five seven Warrant Liabilities In March 2017, April 17, 2015 July 30, 2015 $5.3 December 31, 2016. not .2 11,049 not warrants to purchase 31,167 13,258 April 26, 2017. $6.2 September 30, 2017. In January 2017, d aggregate gross proceeds of $1,300,000 8% March 31, 2017 ( “January 2017 five one hundred 100% January 2017 $5.10 “January 2017 December 2016 25% 137,883 January 2017 April 30, 2017 April 2017, $1.3 The January 2017 January 2017 January 2017 January 2017 January 2017 In connection with the Subscription Agreement described above, the number of Shamus warrants issued as part of the December 2016 75% 100% 14,706 The warrant liabilities were calculated using the Black-Scholes model based upon the following assumptions : September 30 , 201 7 Expected volatility 93.56 % Risk-free interest rate 1.62 % Weighted average expected lives in years 2.54 Expected dividend 0 % We have issued warrants to purchase common stock in February 2012, April 2015, July 2015, August 2016, December 2016, January 2017, February 2017, March 2017, April 2017, June 2017. Fo r the three nine September 30, 2017, $2,000 $1.8 $1.4 $673,000 2016, Derivative Liability In July 2015, a $3.55 12% January 18, 2016 “July 2015 July 2015 $11.40 may October 2016, July 2015 January 18, 2016 January 18, 2017. July 2015 $1.80 July 2015 12% July 2015 April 30, 2017 April 2017, July 2015 2,385,111 Fo r the three nine September 30, 2017, $0 $132,000, $3.5 $6.3 2016, Recently Issued or Newly Adopted Accounting Standards In April 2016, 2016 10, Revenue from Contracts with Customers (Topic 606 2016 10” 2014 09, 2014 09 December 15, 2017. 2016 10 In March 2016, 2016 09, Compensation — Stock Compensation (Topic 718 2016 09” December 15, 2016, The adoption of ASU 2016 09 not

Note 3 - Related Party Disclosu

Note 3 - Related Party Disclosure	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	Note 3 . Related Party Disclosure In January 2017, d aggregate gross proceeds of $1.3 254,904 April 2017, $1.3 In January 2017, December 2016 75% 100% 137,883 In March 2017, July 2015 not .2 warrants to purchase 31,167 April 2017. In April 2017, 181,154 for $869,539 In April 2017, July 2015 totaling $4.3 2,385,111 In April 2017, December 2016 8% $2.9 In April 2017, $1.1 233,734 , resulting in a loss on settlement of liability totaling $83,807 In addition, we have accounts payable outstanding with Mr. Peizer for travel and expenses of approximately $223,000 September 30, 2017. In January 2017, December 2016 75% 100% 14,706 In March 2017, $1.3 December 2016 2 76,204

Note 4 - Short-term Debt

Note 4 - Short-term Debt	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Debt Disclosure [Text Block]	Note 4 . Short-term Debt In January 2017, $1,300,000 8% March 31, 2017 ( “January 2017 254,904 five one hundred 100% January 2017 $5.10 “January 2017 December 2016 25% 137,883 January 2017 April 30, 2017 April 2017, $1.3

Note 5 - Restatement of Financi

Note 5 - Restatement of Financial Statements	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Accounting Changes and Error Corrections [Text Block]	N ote 5 . Restatement of Financial Statements The prior year financial statements have been retroactively restated to reflect the 1 6 April 25, 2017.

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2017
Accounting Policies [Abstract]
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition Our Catasys contracts are generally designed to provide cash fees to us on a monthly basis or an upfront case rate based on enrolled members. To the extent our contracts may may not twelve
Cost of Sales, Policy [Policy Text Block]	Cost of Services Cost of healthcare services consists primarily of salaries related to our care coaches, outreach specialists and other staff directly involved in member care, healthcare provider claims payments, and fees charged by our third third Trak TM
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash Equivalents and Concentration of Credit Risk We consider all highly liquid investments with an original maturity of three . The deposited cash may September 30, 2017, $6.8 For the nine September 30, 2017, three 90% five 96%
Earnings Per Share, Policy [Policy Text Block]	Basic and Diluted Income ( Loss ) per Share Basic income (loss) per share is computed by dividing the net income (loss) to common stockholders for the period by the weighted average number of shares of common stock outstanding during the period. Diluted income (loss) per share is computed by dividing the net income (loss) for the period by the weighted average number of shares of common stock and dilutive common equivalent shares outstanding during the period. Common equivalent shares, consisting of 2,255,381 1,178,821 nine September 30, 2017 2016, stock options and warrants have been excluded from the diluted earnings per share calculation as their effect is anti-dilutive.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Share-Based Compensation Our 2017 “2017 2,333,334 and an additional 243,853 2010 “2010 422A no ten three five September 30, 2017, 243,853 2,333,334 2017 S hare-based compensation expense attributable to continuing operations were $32,000 $191,000 three nine September 30, 2017, $174,000 $523,000 2016, Stock Options – Employees and Directors We measure and recognize compensation expense for all share-based payment awards made to employees and directors based on estimated fair values on the date of grant. We estimate the fair value of share-based payment awards using the Black-Scholes option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the consolidated statements of operations. Share-based compensation expense recognized for employees and directors for the three nine September 30, 2017 $32,000 $191,000, $174,000 $523,000, 2016, For share-based awards issued to employees and directors, share-based compensation is attributed to expense using the straight-line single option method. Share-based compensation expense recognized in our consolidated statements of operations for the three nine September 30, 2017 2016 There were no three nine September 30, 2017 2016, 2017 three nine September 30, 2017 Weighted Avg. Shares Exercise Price Balance December 31, 2016 244,046 $ 39.06 Granted - $ - Cancelled (193 ) $ (245.47 ) Balance March 31, 2017 243,853 $ 38.90 Granted - $ - Cancelled - $ - Balance June 30, 2017 243,853 $ 38.90 Granted - $ - Cancelled - $ - Balance September 30, 2017 243,853 $ 38.90 The expected volatility assumptions have been based on the historical and expected volatility of our stock, measured over a period generally commensurate with the expected term. The weighted average expected option term for the three and nine September 30, 2017 2016, No. 107 110 As of September 30, 2017, $127,500 2017 1.02 Stock Options and Warrants – Non-employees We account for the issuance of options and warrants for services from non-employees by estimating the fair value of warrants issued using the Black-Scholes pricing model. This model’s calculations include the option or warrant exercise price, the market price of shares on grant date, the weighted average risk-free interest rate, the expected life of the option or warrant, and the expected volatility of our stock and the expected dividends. For options and warrants issued as compensation to non-employees for services that are fully vested and non-forfeitable at the time of issuance, the estimated value is recorded in equity and expensed when the services are performed and benefit is received . For unvested shares, the change in fair value during the period is recognized in expense using the graded vesting method. There were no three nine September 30, 2017 2016. There was no three nine September 30, 2017 2016.
Stockholders' Equity, Policy [Policy Text Block]	Common Stock In April 2017, we entered into an underwriting agreement with Joseph Gunnar & Co., LLC (“Joseph Gunnar”), as underwriter in connection with a public offering of the Company’s securities. Pursuant to the underwriting agreement, we agreed to issue and sell an aggregate 3,125,000 $4.80 $4.464 April 28, 2017. $15.0 Pursuant to the underwriting agreement with Joseph Gunnar, we granted the underwriters a 45 468,750 May, 303,750 $1.5 In connection with the public offering, our common stock began trading on the NASDAQ Capital Market (“NASDAQ”) under the symbol “CATS” beginning on April 26, 2017. In April 2017, one hundred 100% convertible debentures and received 2,982,994 $1.4 nine September 30, 2017. In April 2017, $1.1 233,734 As a result, we recognized a loss on settlement of liability totaling $83,807 In April 2017, 1 6 of our common stock, pursuant to which each six one not No All stock options and warrants to purchase common stock outstanding and our common stock reserved for issuance under our equity incentive plans immediately prior to the reverse stock split were appropriately adjusted by dividing the number of affected shares of common stock by six six There were 0 28,985 three nine September 30, 2017 no 2016.
Income Tax, Policy [Policy Text Block]	Income Taxes We have recorded a full valuation allowance against our otherwise recognizable deferred tax assets as of September 30, 2017. not September 30, 2017. 740, not not We assess our income tax positions and record tax benefits for all years subject to examination based upon our evaluation of the facts, circumstances and information available at the reporting date. For those tax positions where there is greater than 50% may 50% no September 30, 2017
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities recorded at fair value in the consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure fair value. The fair value hierarchy distinguishes between ( 1 2 ’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three three Level Input: Input Definition: Level I Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date. Level II Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date. Level III Unobservable inputs that reflect management ’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The following table summarizes fair value measurements by level at September 30, 2017 Balance at September 30, 2017 (Amounts in thousands) Level I Level II Level III Total Certificates of deposit 106 - - 106 Total assets 106 - - 106 Warrant liabilities - - 41 41 Total liabilities - - 41 41 Financial instruments classified as Level III in the fair value hierarchy as of September 30, 2017, Warrant Liabilities The following table summarizes our fair value measurements using significant Level III inputs, and changes therein, for the three nine September 30, 2017: Level III Level III Warrant Derivative (Dollars in thousands) Liabilities (Dollars in thousands) Liabilities Balance as of December 31, 2016 $ 5,307 Balance as of December 31, 2016 $ 8,122 Issuance of warrants 2,405 Issuance of convertible debentures - Change in fair value 5,181 Change in fair value 10,596 Balance as of March 31, 2017 $ 12,893 Balance as of March 31, 2017 $ 18,718 Issuance (exercise) of warrants, net 269 Issuance of convertible debentures - Change in fair value (6,950 ) Change in fair value (10,728 ) Write off of warrants (6,174 ) Write off of derivative liability (7,990 ) Balance as of June 30, 2017 $ 38 Balance as of June 30, 2017 $ - Issuance (exercise) of warrants, net - Issuance of convertible debentures - Expiration of warrants - Expiration of warrants - Change in fair value 2 Change in fair value - Balance as of September 30, 2017 $ 40 Balance as of September 30, 2017 $ -
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Additions and improvements to property and equipment are capitalized at cost. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, which range from two seven five seven
Warrant Liabilities, Policy [Policy Text Block]	Warrant Liabilities In March 2017, April 17, 2015 July 30, 2015 $5.3 December 31, 2016. not .2 11,049 not warrants to purchase 31,167 13,258 April 26, 2017. $6.2 September 30, 2017. In January 2017, d aggregate gross proceeds of $1,300,000 8% March 31, 2017 ( “January 2017 five one hundred 100% January 2017 $5.10 “January 2017 December 2016 25% 137,883 January 2017 April 30, 2017 April 2017, $1.3 The January 2017 January 2017 January 2017 January 2017 January 2017 In connection with the Subscription Agreement described above, the number of Shamus warrants issued as part of the December 2016 75% 100% 14,706 The warrant liabilities were calculated using the Black-Scholes model based upon the following assumptions : September 30 , 201 7 Expected volatility 93.56 % Risk-free interest rate 1.62 % Weighted average expected lives in years 2.54 Expected dividend 0 % We have issued warrants to purchase common stock in February 2012, April 2015, July 2015, August 2016, December 2016, January 2017, February 2017, March 2017, April 2017, June 2017. Fo r the three nine September 30, 2017, $2,000 $1.8 $1.4 $673,000 2016,
Derivatives, Policy [Policy Text Block]	Derivative Liability In July 2015, a $3.55 12% January 18, 2016 “July 2015 July 2015 $11.40 may October 2016, July 2015 January 18, 2016 January 18, 2017. July 2015 $1.80 July 2015 12% July 2015 April 30, 2017 April 2017, July 2015 2,385,111 Fo r the three nine September 30, 2017, $0 $132,000, $3.5 $6.3 2016,
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued or Newly Adopted Accounting Standards In April 2016, 2016 10, Revenue from Contracts with Customers (Topic 606 2016 10” 2014 09, 2014 09 December 15, 2017. 2016 10 In March 2016, 2016 09, Compensation — Stock Compensation (Topic 718 2016 09” December 15, 2016, The adoption of ASU 2016 09 not

Note 2 - Summary of Significa13

Note 2 - Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2017
Notes Tables
Share-based Compensation, Stock Options, Activity [Table Text Block]	Weighted Avg. Shares Exercise Price Balance December 31, 2016 244,046 $ 39.06 Granted - $ - Cancelled (193 ) $ (245.47 ) Balance March 31, 2017 243,853 $ 38.90 Granted - $ - Cancelled - $ - Balance June 30, 2017 243,853 $ 38.90 Granted - $ - Cancelled - $ - Balance September 30, 2017 243,853 $ 38.90
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	Balance at September 30, 2017 (Amounts in thousands) Level I Level II Level III Total Certificates of deposit 106 - - 106 Total assets 106 - - 106 Warrant liabilities - - 41 41 Total liabilities - - 41 41
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Level III Level III Warrant Derivative (Dollars in thousands) Liabilities (Dollars in thousands) Liabilities Balance as of December 31, 2016 $ 5,307 Balance as of December 31, 2016 $ 8,122 Issuance of warrants 2,405 Issuance of convertible debentures - Change in fair value 5,181 Change in fair value 10,596 Balance as of March 31, 2017 $ 12,893 Balance as of March 31, 2017 $ 18,718 Issuance (exercise) of warrants, net 269 Issuance of convertible debentures - Change in fair value (6,950 ) Change in fair value (10,728 ) Write off of warrants (6,174 ) Write off of derivative liability (7,990 ) Balance as of June 30, 2017 $ 38 Balance as of June 30, 2017 $ - Issuance (exercise) of warrants, net - Issuance of convertible debentures - Expiration of warrants - Expiration of warrants - Change in fair value 2 Change in fair value - Balance as of September 30, 2017 $ 40 Balance as of September 30, 2017 $ -
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]	September 30 , 201 7 Expected volatility 93.56 % Risk-free interest rate 1.62 % Weighted average expected lives in years 2.54 Expected dividend 0 %

Note 2 - Summary of Significa14

Note 2 - Summary of Significant Accounting Policies (Details Textual)	Apr. 28, 2017USD ($)$ / sharesshares	Apr. 25, 2017	May 31, 2017USD ($)shares	Apr. 30, 2017USD ($)shares	Jan. 31, 2017USD ($)$ / sharesshares	Sep. 30, 2017USD ($)shares	Jun. 30, 2017shares	Mar. 31, 2017shares	Sep. 30, 2016USD ($)shares	Sep. 30, 2017USD ($)shares	Sep. 30, 2016USD ($)shares	Dec. 31, 2016USD ($)	Oct. 31, 2016$ / shares	Jul. 31, 2015USD ($)$ / shares
Cash, Uninsured Amount						$ 6,800,000				$ 6,800,000
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares										2,255,381	1,178,821
Share-based Compensation										$ 191,000	$ 523,000
Proceeds from Issuance of Common Stock										16,458,000
Gain (Loss) on Conversion of Debt										(1,356,000)
Gain (Loss) on Issuance of Common Stock										(145,000)
Income Tax Expense (Benefit)						2,000			2,000	4,000	7,000
Warrant Liabilities, Noncurrent						41,000				41,000		$ 5,307,000
Repayments of Convertible Debt										4,363,000
Fair Value Adjustment of Warrants						2,000			(1,423,000)	(1,767,000)	(673,000)
Derivative, Gain (Loss) on Derivative, Net						$ 0			$ (3,500,000)	132,000	$ (6,300,000)
Amended Warrants [Member]
Warrant Liabilities, Noncurrent												$ 5,300,000
Class of Warrant or Right, Number of Additional Securities Called by Each Warrant or Right | shares								0.2
Write-off of Warrant Liability										6,200,000
Warrants Not Subject to Amendment [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares								11,049
Domestic Tax Authority [Member]
Income Tax Expense (Benefit)										$ 0
Common Stock Issued for Investor Relation Services [Member]
Stock Issued During Period, Shares, Issued for Services | shares						0			0	28,985	0
Reverse Stock Split [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio		6				6				6
Chairman and Chief Executive Officer [Member]
Deferred Salary Settled by Shares				$ 1,100,000
Common Stock Issued for Settlement of Deferred Salary Balance | shares				233,734
Gain (Loss) on Issuance of Common Stock				$ (83,807)
Acuitas [Member] | January 2017 Convertible Debenture [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares					254,904
Proceeds from Issuance of Debt					$ 1,300,000
Debt Instrument, Interest Rate, Stated Percentage					8.00%
Repayments of Convertible Debt				$ 1,300,000
Acuitas [Member] | Amended Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares				31,167				31,167
Acuitas [Member] | January 2017 Warrants [Member]
Warrant Term					5 years
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion					100.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares					$ 5.10
Acuitas [Member] | December 2016 Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares					137,883
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion												25.00%
Class of Warrant or Right, Additional Percent of Securities Called by Warrants or Rights Upon Conversion					25.00%
Shamus [Member] | Shamus Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares					14,706
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion					100.00%							75.00%
July 2015 Convertible Debenture [Member] | Acuitas [Member]
Debt Conversion, Converted Instrument, Shares Issued | shares				2,385,111
Debt Instrument, Interest Rate, Stated Percentage														12.00%
Debt Instrument, Face Amount														$ 3,550,000
Debt Instrument, Convertible, Conversion Price | $ / shares													$ 1.80	$ 11.40
Several Investors, Including Acuitas and Shamus [Member] | Convertible Debentures [Member]
Debt Conversion, Converted Instrument, Shares Issued | shares				2,982,994
Gain (Loss) on Conversion of Debt										$ (1,400,000)
Accredited Investor [Member] | Amended Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares								13,258
Public Offering [Member] | Acuitas [Member]
Stock Issued During Period, Shares, New Issues | shares				181,154
Proceeds from Issuance of Common Stock				$ 869,539
Public Offering [Member] | Joseph Gunnar & Co., LLC [Member]
Stock Issued During Period, Shares, New Issues | shares	3,125,000
Shares Issued, Price Per Share | $ / shares	$ 4.80
Shares Issued, Price Per Share, Net | $ / shares	$ 4.464
Proceeds from Issuance of Common Stock	$ 15,000,000
Over-Allotment Option [Member] | Joseph Gunnar & Co., LLC [Member]
Stock Issued During Period, Shares, New Issues | shares			303,750
Proceeds from Issuance of Common Stock			$ 1,500,000
Additional Shares Available for Purchase | shares	468,750
Employees and Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares
Minimum [Member] | Furniture and Equipment [Member]
Property, Plant and Equipment, Useful Life										2 years
Minimum [Member] | Leasehold Improvements [Member]
Property, Plant and Equipment, Useful Life										5 years
Maximum [Member] | Furniture and Equipment [Member]
Property, Plant and Equipment, Useful Life										7 years
Maximum [Member] | Leasehold Improvements [Member]
Property, Plant and Equipment, Useful Life										7 years
The 2017 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares						2,333,334				2,333,334
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period										10 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares						243,853				243,853
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares						2,333,334				2,333,334
Share-based Compensation						$ 32,000			$ 174,000	$ 191,000	$ 523,000
The 2017 Stock Incentive Plan [Member] | Employees and Directors [Member]
Share-based Compensation						$ 32,000			$ 174,000	$ 191,000	$ 523,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares						0			0	0	0
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized						$ 127,500				$ 127,500
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition										1 year 7 days
The 2017 Stock Incentive Plan [Member] | Nonemployees [Member]
Share-based Compensation						$ 0			$ 0	$ 0	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares						0			0	0	0
The 2017 Stock Incentive Plan [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period										3 years
The 2017 Stock Incentive Plan [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period										5 years
The 2010 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares						243,853				243,853
Sales Revenue, Net [Member] | Customer Concentration Risk [Member]
Number of Major Customers										3
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Three Customers [Member]
Concentration Risk, Percentage										90.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member]
Number of Major Customers										5
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Five Customers [Member]
Concentration Risk, Percentage										96.00%

Note 2 - Summary of Significa15

Note 2 - Summary of Significant Accounting Policies - Employee and Director Stock Option Activity (Details) - Employees and Directors [Member] - $ / shares	3 Months Ended			9 Months Ended
	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Sep. 30, 2017
Balance (in shares)	243,853	243,853	244,046	244,046
Balance, weighted average exercise price (in dollars per share)	$ 38.90	$ 38.90	$ 39.06	$ 39.06
Granted (in shares)
Granted, weighted average exercise price (in dollars per share)
Cancelled (in shares)			(193)
Cancelled, weighted average exercise price (in dollars per share)			$ (245.47)
Cancelled (in shares)			193
Cancelled, weighted average exercise price (in dollars per share)			$ 245.47
Balance (in shares)	243,853	243,853	243,853	243,853
Balance, weighted average exercise price (in dollars per share)	$ 38.90	$ 38.90	$ 38.90	$ 38.90

Note 2 - Summary of Significa16

Note 2 - Summary of Significant Accounting Policies - Fair Value, Assets and Liabilities Measured on a Recurring Basis (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Total assets	$ 106
Warrant liabilities	41	$ 5,307
Total liabilities	41
Certificates of Deposit [Member]
Certificates of deposit	106
Fair Value, Inputs, Level 1 [Member]
Total assets	106
Warrant liabilities
Total liabilities
Fair Value, Inputs, Level 1 [Member] | Certificates of Deposit [Member]
Certificates of deposit	106
Fair Value, Inputs, Level 2 [Member]
Total assets
Warrant liabilities
Total liabilities
Fair Value, Inputs, Level 2 [Member] | Certificates of Deposit [Member]
Certificates of deposit
Fair Value, Inputs, Level 3 [Member]
Total assets
Warrant liabilities	41
Total liabilities	41
Fair Value, Inputs, Level 3 [Member] | Certificates of Deposit [Member]
Certificates of deposit

Note 2 - Summary of Significa17

Note 2 - Summary of Significant Accounting Policies - Fair Value Measurements Using Significant Level III Inputs (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017
Warrants [Member]
Balance	$ 38	$ 12,893	$ 5,307
Issuance (exercise) of warrants, net		269	2,405
Change in fair value	2	(6,950)	5,181
Write off of warrants		(6,174)
Balance	40	38	12,893
Derivative Financial Instruments, Liabilities [Member]
Balance		18,718	8,122
Issuance (exercise) of warrants, net
Change in fair value		(10,728)	10,596
Write off of warrants		(7,990)
Balance			$ 18,718

Note 2 - Summary of Significa18

Note 2 - Summary of Significant Accounting Policies - Fair Value Assumptions (Details) - Warrant Liability [Member]	9 Months Ended
	Sep. 30, 2017
Expected volatility	93.56%
Risk-free interest rate	1.62%
Weighted average expected lives in years (Year)	2 years 197 days
Expected dividend	0.00%

Note 3 - Related Party Disclo19

Note 3 - Related Party Disclosure (Details Textual) - USD ($)	1 Months Ended			3 Months Ended		9 Months Ended
	Apr. 30, 2017	Mar. 31, 2017	Jan. 31, 2017	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Jul. 31, 2015
Repayments of Convertible Debt						$ 4,363,000
Proceeds from Issuance of Common Stock						16,458,000
Gain (Loss) on Issuance of Common Stock						(145,000)
Due to Related Parties, Current								$ 9,796,000
Amended Warrants [Member]
Class of Warrant or Right, Number of Additional Securities Called by Each Warrant or Right		0.2
Acuitas [Member] | July 2015 Convertible Debenture [Member]
Debt Conversion, Original Debt, Amount	$ 4,300,000
Debt Conversion, Converted Instrument, Shares Issued	2,385,111
Debt Instrument, Interest Rate, Stated Percentage									12.00%
Acuitas [Member] | December 2016 Convertible Debenture [Member]
Repayments of Convertible Debt	$ 2,900,000
Debt Instrument, Interest Rate, Stated Percentage	8.00%
Acuitas [Member] | Public Offering [Member]
Stock Issued During Period, Shares, New Issues	181,154
Proceeds from Issuance of Common Stock	$ 869,539
Acuitas [Member] | Acuitas Warrants [Member]
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion								75.00%
Acuitas [Member] | Amended Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	31,167	31,167
Acuitas [Member] | January 2017 Convertible Debenture [Member]
Proceeds from Issuance of Debt			$ 1,300,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			254,904
Repayments of Convertible Debt	$ 1,300,000
Debt Instrument, Interest Rate, Stated Percentage			8.00%
Shamus [Member] | Conversion Of December 2016 Convertible Debentures Into Common Stock [Member]
Debt Conversion, Original Debt, Amount		$ 1,300,000
Debt Conversion, Converted Instrument, Shares Issued		276,204
Shamus [Member] | Acuitas Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			137,883
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion			100.00%
Shamus [Member] | Shamus Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			14,706
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion			100.00%					75.00%
Chairman and Chief Executive Officer [Member]
Deferred Salary Settled by Shares	$ 1,100,000
Common Stock Issued for Settlement of Deferred Salary Balance	233,734
Gain (Loss) on Issuance of Common Stock	$ (83,807)
Chairman and Chief Executive Officer [Member] | Travel and Expenses [Member]
Due to Related Parties, Current				$ 223,000		$ 223,000

Note 4 - Short-term Debt (Detai

Note 4 - Short-term Debt (Details Textual) - USD ($)	1 Months Ended		9 Months Ended
	Apr. 30, 2017	Jan. 31, 2017	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Repayments of Convertible Debt			$ 4,363,000
Acuitas [Member] | January 2017 Warrants [Member]
Warrant Term		5 years
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion		100.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 5.10
Acuitas [Member] | December 2016 Warrants [Member]
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion					25.00%
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		137,883
Acuitas [Member] | January 2017 Convertible Debenture [Member]
Proceeds from Issuance of Debt		$ 1,300,000
Debt Instrument, Interest Rate, Stated Percentage		8.00%
Class of Warrant or Right, Issued During Period		254,904
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		254,904
Repayments of Convertible Debt	$ 1,300,000

Note 5 - Restatement of Finan21

Note 5 - Restatement of Financial Statements (Details Textual)	Apr. 25, 2017	Sep. 30, 2017	Sep. 30, 2017
Reverse Stock Split [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio	6	6	6